Effect of vitamin B12 in treatment of fatty liver disease
- Conditions
- on-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedK76.0
- Registration Number
- IRCT20120718010333N5
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Patients who are diagnosed to have non alcoholic fatty liver disease confirmed with ultrasonography result
Ages between 18-80 years
Serum alanine transaminase enzyme level higher than 30 U/L in men
Serum alanine transaminase enzyme level higher than 19 U/L in women
Pregnancy
Lactation
Alcohol consumption greater than 20 g per day
Having diseases such as hereditary hemochromatosis, Wilson's disease and a1 antitripsin enzyme deficiency
History of jejunoileal bypass surgery or gastroplasty
History of receiving total parenteral nutrition during last 6 months
Consumption of statins and hepatotoxic drugs such as calcium channel blocker, methotrexate, amiodarone, chloroquine
History of hypothyroidism and Cushing's syndrome
Intake of folate, B12, vitamin E and omega-3 supplements during the last 3 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method